According to Zhitong Finance App, Hengrui Pharmaceutical (01276) issued an announcement. As of August 31, 2026, the company has not yet begun to implement share repurchases. As of the disclosure date of this announcement, there is no difference between the implementation status of this repurchase and the share repurchase plan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.